Why is Remedium Life falling/rising?

As of 09-Sep, Remedium Lifecare Ltd's stock price is currently at 1.44, showing no change (0.00%). The stock has outperformed its sector by 1.34% today, and its performance over the past week and month has been positive, with returns of +9.09% and +19.01%, respectively. However, the stock has a concerning long-term performance, with a year-to-date decline of -59.71% and a one-year drop of -79.43%. The company has reported significant losses, including a negative return on capital employed (ROCE) and a high Debt to EBITDA ratio of -1.00 times, indicating a low ability to service debt. Additionally, the company has faced a drastic fall in net sales of -76.36% and has declared negative results for the last four consecutive quarters, which negatively impacts investor sentiment.
In the broader market context, while the Sensex has shown a modest gain of +1.18% over the past week, Remedium Lifecare's short-term performance has been notably better, suggesting some investor interest despite the company's ongoing struggles. However, the stock's long-term performance remains significantly worse than the benchmark, which has only declined by -0.56% over the past year. The falling investor participation, with a delivery volume decrease of -20.63% against the five-day average, further indicates a lack of confidence in the stock. Overall, despite some recent positive movements, the underlying financial issues and poor long-term growth prospects contribute to a challenging outlook for Remedium Lifecare Ltd.